Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Carnival Corporation : to Provide Convenient Access to Pre-Board Testing; Guests may schedule appointments for COVID-19 viral testing from Quest Diagnostics at 1,500 locations nationwide

09/13/2021 | 11:34am EDT

MIAMI - Carnival Corporation & plc (NYSE/LSE: CCL; NYSE: CUK), the world's largest cruise company, today announced a new initiative making pre-board testing more convenient and accessible for its guests. The effort will facilitate access to pre-cruise COVID-19 viral testing for guests of Carnival Cruise Line, Holland America Line, Princess Cruises and Seabourn at more than 1,500 convenient Quest Diagnostics (NYSE: DGX) patient service centers and retail pharmacy testing locations throughout the U.S.

The program helps streamline pre-cruise preparation for guests planning to sail aboard Carnival Cruise Line, Princess Cruises, Holland America Line or Seabourn. Currently, all guests, regardless of vaccination status, must present a negative COVID-19 viral test taken no more than three days before their embarkation, along with additional health and safety requirements. Beginning September 13, 2021 and after, in accordance with CDC directives, all vaccinated guests must present a negative COVID-19 viral test taken no more than two days before their embarkation (for example, if a cruise leaves on a Saturday, guests should schedule their tests for the Thursday before embarking). Details about requirements are available on the Carnival Corporation cruise line brand websites.

The pre-board test (molecular or antigen) is one of the added measures recently implemented by the company's cruise lines, which have been operating with enhanced health and safety protocols designed to change as needed to adapt to the evolving public health environment.

'Access to testing continues to play an important role in the restart of our guest operations, and working with Quest simplifies the process for our guests by making it easier to access convenient testing options from a trusted national laboratory provider,' said Roger Frizzell, chief communications officer for Carnival Corporation. 'These testing protocols are part of our layered approach to safeguarding the health and safety of our guests, crew and the communities we visit.'

Guests may schedule testing with Quest Diagnostics at more than 1,500 locations, including Quest Diagnostics patient service centers and select Walmart and other retail pharmacy locations throughout the U.S. Appointments are required and may be scheduled online via secure link provided by Carnival Cruise Line, Princess Cruises, Holland America Line or Seabourn. Results are typically available within 48 hours via email or mobile application*.

Carnival Corporation has worked closely with health and medical experts globally and nationally, as well as with authorities in destination countries, to put in place comprehensive health and safety protocols for protection and mitigation across the entire cruise experience for all of the company's nine brands. This includes cross-industry learnings and best practices based on the proven health and safety record of industrywide sailings, and input from top scientists and public health, epidemiological and policy experts. Details about enhanced protocols, including the latest information and requirements for each Carnival Corporation cruise line brand, are available at their websites.

*Turnaround time can fluctuate with demand, supplies and other factors, and vary by region.

About Carnival Corporation & plc

Carnival Corporation & plc is one of the world's largest leisure travel companies with a portfolio of nine of the world's leading cruise lines sailing to all seven continents. With operations in North America, Australia, Europe and Asia, its portfolio features Carnival Cruise Line, Princess Cruises, Holland America Line, Seabourn, P&O Cruises (Australia), Costa Cruises, AIDA Cruises, P&O Cruises (UK) and Cunard.

Additional information can be found on www.carnivalcorp.com, www.carnival.com, www.princess.com, www.hollandamerica.com, www.seabourn.com, www.pocruises.com.au, www.costacruise.com, www.aida.de, www.pocruises.com and www.cunard.com.

SOURCE Carnival Corporation & plc

Roger Frizzell, Carnival Corporation, rfrizzell@carnival.com, (305) 406-7862, Mike Flanagan, LDWW, mike@ldww.co, (727) 452-4538

(C) 2021 Electronic News Publishing, source ENP Newswire

Stocks mentioned in the article
ChangeLast1st jan.
CARNIVAL CORPORATION & PLC -0.49% 22.33 Delayed Quote.3.60%
QUEST DIAGNOSTICS INCORPORATED -1.01% 145.36 Delayed Quote.21.98%
10:20aCARNIVAL & : Berenberg Upgrades Carnival Corporation to Hold from Sells, Lifts Price Targe..
08:22aCARNIVAL & : Berenberg Lifts Carnival PT, Keeps Hold Rating
05:59aANALYST RECOMMENDATIONS : Ford, Hilton, IBM, Johnson & Johnson, Netflix...
10/20European ADRs Move Slightly Higher in Wednesday Trading
10/20CARNIVAL & : Corporation Purchase of Shares
10/20CARNIVAL & : Announces Upsizing and Pricing of $2.0 Billion Senior Unsecured Notes due 202..
10/20CARNIVAL CORP : Other Events, Financial Statements and Exhibits (form 8-K)
10/20CARNIVAL PLC : Other Events, Financial Statements and Exhibits (form 8-K)
10/20CARNIVAL & : Prices $2 Billion Senior Notes in Upsized Private Offering
10/20CARNIVAL & : Prices $2 Billion Senior Unsecured Notes Due 2029
More news
Analyst Recommendations on CARNIVAL CORPORATION & PLC
More recommendations
Financials (USD)
Sales 2021 2 148 M - -
Net income 2021 -7 768 M - -
Net Debt 2021 26 052 M - -
P/E ratio 2021 -3,10x
Yield 2021 -
Capitalization 25 062 M 25 062 M -
EV / Sales 2021 23,8x
EV / Sales 2022 3,02x
Nbr of Employees 70 000
Free-Float 67,2%
Duration : Period :
Carnival Corporation & plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CARNIVAL CORPORATION & PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 22,33 $
Average target price 28,70 $
Spread / Average Target 28,5%
EPS Revisions
Managers and Directors
Arnold W. Donald President, Chief Executive Officer & Director
David Bernstein Chief Financial & Accounting Officer
Micky Meir Arison Chairman
Gregory A. Sullivan Chief Information Officer
Josh Weinstein Chief Operating Officer
Sector and Competitors